News

Implantable device stops seizures at the first signs of an episode

10 September 2018

Implantable Device Stops Seizures at the First Signs of an Episode A new device from researchers at the University of Cambridge, École Nationale Supérieure des Mines and French National Institute of Health and Medical Research (INSERM) in France can stop seizures at the first symptom. So far researchers have implanted the...

Protein discovery may explain why some patients develop resistance to new class of anti-cancer drugs

26 July 2018

A team of researchers at the University of Cambridge has identified a protein complex that might explain why some cancer patients treated with the revolutionary new anti-cancer drugs known as PARP inhibitors develop resistance to their medication. As we improve our understanding of these DNA repair networks and how they...

Making sense of cancer’s ‘big data’ problem to revolutionise patient care

12 July 2018

A new institute at the University of Cambridge aims to revolutionise cancer care by using cutting edge analytics to maximize the use of big data sets collected from patients. Integrated cancer medicine offers the promise of turning the tsunami of data generated in medical practice into an extraordinarily powerful but...

Cambridge partners with industry leaders to fund research on global sustainability challenges

12 July 2018

The Prince of Wales Global Sustainability Fellowship Programme represents a multi-million-pound commitment from the private sector to accelerate progress on UN Sustainable Development Goals. The Prince of Wales Global Sustainability Fellowship Programme will create a rich intellectual space for collaboration between...

Spin-out Morphogen-IX announces appointment of CEO and SAB members

6 July 2018

Morphogen-IX Ltd , a preclinical biotechnology company focused on the development of bone morphogenetic proteins for the treatment of pulmonary arterial hypertension (PAH), today announced the appointment of Professor Nick Morrell as CEO. Morrell co-founded the company in 2015 based on research from his lab at the...

Low-cost plastic sensors could monitor a range of health conditions

3 July 2018

An international team of researchers have developed a low-cost sensor made from semiconducting plastic that can be used to diagnose or monitor a wide range of health conditions, such as surgical complications or neurodegenerative diseases. This work opens up new directions in biosensing, where materials can be designed to...

MPhil in Biotechnology

28 June 2018

New MPhil in Biotechnology – interdisciplinary training and a pathway for physicists, engineers, mathematicians and computer scientists to get into the biological sciences The Department of Chemical Engineering and Biotechnology is launching a new MPhil in Biotechnology, now recruiting the first cohort to start in October...

Cambridge and Nokia Bell Labs establish new research center to advance AI-supported multi-sensory personal devices

21 June 2018

The long-sought dream of wearable and mobile devices that will interpret, replicate and influence people’s emotions and perceptions will soon be a reality thanks to a collaboration between the University and Nokia Bell Labs. Nokia Bell Labs is a founding partner of the new Centre for Mobile, Wearable Systems and Augmented...

New 3D imaging analysis technique could lead to improved arthritis treatment

18 June 2018

An algorithm to monitor the joints of patients with arthritis, which could change the way that the severity of the condition is assessed, has been developed by a team of engineers, physicians and radiologists led by the University of Cambridge. Using this technique, we’ll hopefully be able to identify osteoarthritis...

Rosalind Franklin Institute to harness disruptive technology to transform drug discovery

8 June 2018

Business Secretary Greg Clark today announced funding for a series of ambitious technology projects that will transform the way medicines are discovered, enabling the pharmaceutical industry to develop groundbreaking drugs faster, cheaper and better than ever before. Our partnership in the institute gives us access to, and...